<SEC-DOCUMENT>0001654954-19-012904-index.html : 20191114
<SEC-HEADER>0001654954-19-012904.hdr.sgml : 20191114
<ACCEPTANCE-DATETIME>20191114090010
ACCESSION NUMBER:		0001654954-19-012904
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20191113
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20191114
DATE AS OF CHANGE:		20191114

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AzurRx BioPharma, Inc.
		CENTRAL INDEX KEY:			0001604191
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37853
		FILM NUMBER:		191216705

	BUSINESS ADDRESS:	
		STREET 1:		760 PARKSIDE AVENUE
		STREET 2:		SUITE 304
		CITY:			BROOKLYN
		STATE:			NY
		ZIP:			11226
		BUSINESS PHONE:		646-699-7855

	MAIL ADDRESS:	
		STREET 1:		760 PARKSIDE AVENUE
		STREET 2:		SUITE 304
		CITY:			BROOKLYN
		STATE:			NY
		ZIP:			11226

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BioPharma d'Azur, Inc.
		DATE OF NAME CHANGE:	20140331
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>azrx8k.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
Document 1 - file: azrx8k.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10
<SEQUENCE>2
<FILENAME>ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
Document 2 - file: ex10-1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10
<SEQUENCE>3
<FILENAME>ex10-2.htm
<DESCRIPTION>EXHIBIT 10.2
<TEXT>
Document 3 - file: ex10-2.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>4
<FILENAME>ex99-1.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
Document 4 - file: ex99-1.htm

</DOCUMENT>
</SEC-DOCUMENT>